Insights Companies Sectors Directors Investors Compare

RegisterKaro › MCA registered Company Details

Indegene

L73100KA1998PLC102040ActivePrivateUnlisted

Last updated: 2026-06-08

Compliance Health · F

3 / 9 signals passed

Indegene is a Private Indian company incorporated in 1998 and based in Karnataka, India. Indegene operates in R&D (NIC 73100) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.

Risk FlagsFinancials not yet extracted · awaiting AOC-4 XBRLDirectors not yet extracted · awaiting MGT-7Health F · 30/100

Revenue (latest FY)

—

Awaiting extraction

PAT (latest FY)

—

Awaiting extraction

Open Charges

No encumbrances

Active Directors

No resignations

Paid-up Capital

—

Filings on Record

All current

Incorporated

1998

28 years old

State

Karnataka

Sector

R&D

NIC 73100

Class

Private

Sub-category

—

Authorized Capital

—

Paid-up Capital

—

Members

—

Last AGM

—

Last Balance Sheet

—

Latest Filing

—

Registered Email

—

Registered Office

—

IndegeneTRACXN · PUBLIC DATA

Brand Indegene · Legal entity Indegene

Indegene - Suite solutions for payers and healthcare providers. Public Company. Raised a total funding of $255M over 4 rounds from 19 investors.

Total Funding

Latest Round

Series C

Revenue

Valuation

Funding Rounds

—

Employees

5,666

Stage

Public

Princeton

Founded

1998

Source: Tracxn (public profile) · joined to MCA on CIN L73100KA1998PLC102040

Quick facts

Identity · Activity · Auditor · Contact

Registered office

—

NIC code

73100

Statutory auditor

Awaiting ADT-1 / AOC-4 extraction

Registered email

—

Section

R&D

ROC

—

Website

https://www.indegene.com/

Class · sub-category

Private

Incorporation · Last AGM

— · —

Directors

From MGT-7 annual returnLocked

Kunal Bhatia

Whole-time Director

3.8y · Pune · DIN 3885224

Vikram Singh Rathore

Director

7.0y · Gurugram · DIN 2302182

Deepa Reddy

Additional Director

2.6y · Pune · DIN 6222475

Get the full board of directors

Directors, DINs & appointment history for Indegene.

~~₹499~~₹169(excl. taxes)

Buy Financial & Company Filings

What you'll get

Incorporation Documents
Change in Directors & Designated Partner
Board Resolutions
Financial Statements & Annual Filings
Charge Documents (Summary)

MCA Filings

AOC-4 · MGT-7 historyLocked

Form	FY	Filed	Due	Delay	Status
AOC-4	FY2024-25	30 Oct 2024	30 Oct 2024	+18d	filed
MGT-7	FY2024-25	24 Nov 2024	29 Nov 2024	0d	filed
AOC-4	FY2023-24	30 Oct 2023	30 Oct 2023	+36d	filed
MGT-7	FY2023-24	27 Nov 2023	29 Nov 2023	0d	filed
AOC-4	FY2022-23	30 Oct 2022	30 Oct 2022	0d	filed
MGT-7	FY2022-23	22 Nov 2022	29 Nov 2022	0d	filed

Get financial statements & other filing documents

Full MCA filing history for Indegene.

~~₹499~~₹169(excl. taxes)

Buy Financial & Company Filings

What you'll get

Incorporation Documents
Change in Directors & Designated Partner
Board Resolutions
Financial Statements & Annual Filings
Charge Documents (Summary)

Charges

Registered charges & encumbrancesLocked

Charge ID	Holder	Amount	Created	Status
119696322	State Bank of India(Bank)	₹19.20 Cr	04 Jul 2020	Open
776378429	State Bank of India(Bank)	₹21.54 Cr	27 Jan 2020	Open
371494537	Axis Bank Ltd(Bank)	₹15.66 Cr	04 Jul 2021	Satisfied
149438295	ICICI Bank Ltd(Bank)	₹4.46 Cr	27 Jan 2021	Open
258170473	HDFC Bank Ltd(Bank)	₹19.02 Cr	04 Jul 2019	Satisfied

See registered charges & lenders

Charge IDs, lenders & amounts for Indegene.

~~₹499~~₹169(excl. taxes)

Buy Financial & Company Filings

What you'll get

Incorporation Documents
Change in Directors & Designated Partner
Board Resolutions
Financial Statements & Annual Filings
Charge Documents (Summary)

Financial Performance

Revenue · PAT · Net worth by FYLocked

FY	Revenue	PAT	Net Worth	Total Assets	Employees
FY2024-25	₹69.14 Cr	₹2.28 Cr	₹54.00 Cr	₹87.36 Cr	117
FY2023-24	₹56.06 Cr	₹1.95 Cr	₹39.10 Cr	₹88.54 Cr	177
FY2022-23	₹57.29 Cr	₹2.60 Cr	₹44.09 Cr	₹83.57 Cr	171
FY2021-22	₹54.36 Cr	₹2.01 Cr	₹31.67 Cr	₹91.95 Cr	285

Gain deeper financial insights of this entity

Audited financials & ratios for Indegene.

~~₹999~~₹249(excl. taxes)

Buy Financial Report

What you'll get

Financial Summary & Charts
Income Statement, Balance Sheet, Cashflow
Profitability, Liquidity & Growth Ratios
Audited Financial Statement (AOC-4)

Detailed Financials

Income statement + balance sheetLocked

Line item	FY2024-25	FY2023-24	FY2022-23	FY2021-22
Income statement
Revenue from operations	₹69.14 Cr	₹56.06 Cr	₹57.29 Cr	₹54.36 Cr
Other income	₹1.71 Cr	₹1.12 Cr	₹94.97 L	₹55.17 L
Total income	₹70.86 Cr	₹57.17 Cr	₹58.24 Cr	₹54.92 Cr
Total expenses	₹67.94 Cr	₹54.68 Cr	₹54.91 Cr	₹52.34 Cr
Profit before tax	₹2.96 Cr	₹2.53 Cr	₹3.38 Cr	₹2.62 Cr
Profit / (Loss) after tax	₹2.28 Cr	₹1.95 Cr	₹2.60 Cr	₹2.01 Cr
Balance sheet
Equity / Net worth	₹54.00 Cr	₹39.10 Cr	₹44.09 Cr	₹31.67 Cr
Borrowings	₹16.60 Cr	₹16.99 Cr	₹17.50 Cr	₹14.05 Cr
Current liabilities	₹10.52 Cr	₹18.36 Cr	₹15.71 Cr	₹35.75 Cr
Total liabilities	₹33.36 Cr	₹49.44 Cr	₹39.47 Cr	₹60.28 Cr
Current assets	₹51.59 Cr	₹42.36 Cr	₹44.99 Cr	₹44.28 Cr
Cash & equivalents	₹14.68 Cr	₹8.22 Cr	₹9.68 Cr	₹10.91 Cr
Total assets	₹87.36 Cr	₹88.54 Cr	₹83.57 Cr	₹91.95 Cr
Employees	117	177	171	285

Gain deeper financial insights of this entity

Audited financials & ratios for Indegene.

~~₹999~~₹249(excl. taxes)

Buy Financial Report

What you'll get

Financial Summary & Charts
Income Statement, Balance Sheet, Cashflow
Profitability, Liquidity & Growth Ratios
Audited Financial Statement (AOC-4)

Compounded Annual Growth Rate

Derived from multi-FY filingsLocked

Metric	Latest value	1Y CAGR	3Y CAGR	5Y CAGR
Revenue	₹69.14 Cr	-6.4%	+13.8%	+6.5%
Profit after Tax	₹2.28 Cr	-2.6%	+2.0%	+4.7%
Net Worth	₹54.00 Cr	+1.5%	+8.4%	-1.4%
Employees	117	+28.1%	+10.9%	-2.1%

Gain deeper financial insights of this entity

Audited financials & ratios for Indegene.

~~₹999~~₹249(excl. taxes)

Buy Financial Report

What you'll get

Financial Summary & Charts
Income Statement, Balance Sheet, Cashflow
Profitability, Liquidity & Growth Ratios
Audited Financial Statement (AOC-4)

Financial Ratios

Profitability · leverage · efficiencyLocked

FY	Revenue	PAT	PAT margin	Rev growth	ROE	ROA	D/E	Rev/emp
FY2024-25	₹69.14 Cr	₹2.28 Cr	+3.30%	+32.24%	+4.22%	+2.61%	0.31	₹59.10 L
FY2023-24	₹56.06 Cr	₹1.95 Cr	+3.47%	+0.28%	+4.98%	+2.20%	0.43	₹31.67 L
FY2022-23	₹57.29 Cr	₹2.60 Cr	+4.54%	-3.21%	+5.90%	+3.11%	0.40	₹33.50 L
FY2021-22	₹54.36 Cr	₹2.01 Cr	+3.70%	-10.86%	+6.36%	+2.19%	0.44	₹19.08 L

Gain deeper financial insights of this entity

Audited financials & ratios for Indegene.

~~₹999~~₹249(excl. taxes)

Buy Financial Report

What you'll get

Financial Summary & Charts
Income Statement, Balance Sheet, Cashflow
Profitability, Liquidity & Growth Ratios
Audited Financial Statement (AOC-4)

Cap Table & Shareholding

Promoter · institutional · publicLocked

Category	Shareholders	Shares held	%
Promoters	3	3,86,83,481	85.36%
Institutional Investors	1	20,51,564	4.53%
Public & Others	53	45,83,806	10.11%

See the full shareholding pattern

Promoter, institutional & public holding for Indegene.

~~₹499~~₹169(excl. taxes)

Buy Financial & Company Filings

What you'll get

Incorporation Documents
Change in Directors & Designated Partner
Board Resolutions
Financial Statements & Annual Filings
Charge Documents (Summary)

Peer Benchmark

84 peersSame sector (R&D) — nationwide

MetricThis companyCohort medianCohort P75Quartile

Revenue (latest FY)

—

PAT (latest FY)

—

Employees

—

Paid-up capital

—

Compliance Health

Bottom quartile · P8

Top 6 in R&D

by healthView all ›

Ecozen Solutions

PN · Inc 2010

Paid-up

Revenue

C · 63

Avesthagen

Karnataka · Inc 1998

Paid-up

Revenue

C · 63

Pcloudy

Karnataka · Inc 2013

Paid-up

Revenue

C · 63

Teamindus

Delhi · Inc 2011

Paid-up

Revenue

C · 63

Novalead Pharma

PN · Inc 2007

Paid-up

Revenue

C · 63

Infollion

Haryana · Inc 2009

Paid-up

Revenue

C · 63

External data sources

7 plannedWhat lands here as ingestion comes online

GSTIN Registrations

Planned

GST portal

Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.

MSME Payment Delays

Planned

MSME-1 form

Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.

Related Party Transactions

Planned

AOC-4 schedule

Counterparty, nature, transaction value. Inter-company loans, sales, royalty.

Credit Ratings

Planned

CRISIL / ICRA / CARE feeds

Long-term + short-term ratings, with rationale on rating actions.

Trademarks

Planned

IP India Trademark Registry

Applied, registered, opposed. Class numbers + status.

Patents

Planned

IP India Patent Registry

Applications and grants. Inventor names + filing dates.

Legal Cases

Planned

eCourts + Indian Kanoon

Ongoing + past litigations the entity is party to.

Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.

FAQs about Indegene

When was Indegene incorporated?

Indegene was incorporated in 1998. Its CIN is L73100KA1998PLC102040 and it is registered with the relevant Registrar of Companies.

Where is Indegene located?

Indegene is headquartered in Karnataka.

What sector does Indegene operate in?

Indegene operates in the R&D sector (NIC code 73100), classified as Indian Non-Govt Company.

Who are the directors of Indegene?

Director details for Indegene have not yet been extracted from MGT-7 filings.

What is the paid-up capital of Indegene?

Indegene has authorized capital of — and paid-up capital of —.

Does Indegene have any open charges?

Indegene has no open MCA-registered charges on record.

What is Indegene's Compliance Health Score?

RegisterKaro's Compliance Health Score for Indegene is 30/100 (grade F), based on 9 weighted signals across MCA filings, charges, directors, capital, and overall status. 3 of 9 signals passed.